Compound information
- Natural Products
- NACP39441
- Molecular Formula
- C22H24N2O5
- Molecular Weight
- 396.168521868 g/mol
- Structure
-
- IUPAC Name
- 2-[(1-benzyloxycarbonylpyrrolidine-2-carbonyl)amino]-3-phenyl-propanoic acid
- InChI
- InChI=1S/C22H24N2O5/c25-20(23-18(21(26)27)14-16-8-3-1-4-9-16)19-12-7-13-24(19)22(28)29-15-17-10-5-2-6-11-17/h1-6,8-11,18-19H,7,12-15H2,(H,23,25)(H,26,27)
- InChI Key
- GMUYSWQSSRROPG-UHFFFAOYSA-N
- SMILES
- O=C(OCC=1C=CC=CC1)N2CCCC2C(=O)NC(C(=O)O)CC=3C=CC=CC3
- CAS
- 17350-17-3
- SuperClass
- Organic acids and derivatives
- Class
- Carboxylic acids and derivatives
- SubClass
- Amino acids, peptides, and analogues
- Source
- CNP0340446
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 29 | Ring Count | 3 |
Heteroatom Count | 7 | Rotatable Bond Count | 7 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 95.94 Å2 | LogP | 2.737 |
LogS | -3.509 | LogD | 2.048 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.015 | Pgp substrate | 0.049 |
HIA | 0.9 | F20 % | 0.992 |
F30 % | 0.177 | Caco-2 | -5.229 |
MDCK | -5.595 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.163 | PPB | 96.073 |
VD | 0.429 | Fu | 1.137 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.485 |
CYP2A6 substrate | 0.376 | CYP2B6 substrate | 0.419 |
CYP2C19 inhibitor | 0.159 | CYP2C19 substrate | 0.236 |
CYP2C8 substrate | 0.549 | CYP2C9 inhibitor | 0.032 |
CYP2C9 substrate | 0.052 | CYP2D6 inhibitor | 0.091 |
CYP2D6 substrate | 0.3 | CYP2E1 substrate | 0.287 |
CYP3A4 inhibitor | 0.11 | CYP3A4 substrate | 0.491 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.877 | CL | 1.466 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.01 | Hepatotoxicity | 0.862 |
Mutagenicity | 0.023 | Rat Oral Acute Toxicity | 0.564 |
FDAMDD | 0.23 | Skin Sensitization | 0.005 |
Carcinogenicity | 0.01 | Eye Corrosion | 0.001 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.011 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.057 | IGC50 | 2.903 |
LC50FM | 1.78 | LC50DM | 4.678 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.491 | NR-AR-LBD | 0.244 |
NR-AhR | 0.011 | NR-Aromatase | 0.028 |
NR-ER | 0.311 | NR-ER-LBD | 0.38 |
NR-PPAR-gamma | 0.465 | SR-ARE | 0.087 |
SR-ATAD5 | 0.291 | SR-HSE | 0.121 |
SR-MMP | 0.015 | SR-p53 | 0.026 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.